Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice

被引:129
作者
Kim, AL
Labasi, JM
Zhu, YC
Tang, XW
McClure, K
Gabel, CA
Athar, M
Bickers, DR
机构
[1] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA
[2] Pfizer Inc, Dept Inflammat, Global Res & Dev, Groton, CT 06340 USA
关键词
COX-2; inflammatory response; mice; p38; MAPK; UVB;
D O I
10.1111/j.0022-202X.2005.23747.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The p38 mitogen-activated protein kinase (MAPK) signaling pathway is activated by numerous inflammatory mediators and environmental stresses. We assessed the effects of ultraviolet B (UVB) on the p38 MAPK pathway and determined whether cyclooxygenase (COX)-2 expression is downstream of this kinase in the skin of UVB-irradiated SKH-1 mice. SKH-1 mice were irradiated with a single dose of UVB (360 mJ per cm(2)), and activation of the epidermal p38 MAPK pathway was assessed. UVB-induced phosphorylation of p38 MAPK occurred in a time-dependent manner. Phosphorylation of MAPK-activated protein kinase-2 (MAPKAPK-2) also was detected and correlated with an increase in its kinase activity. Phosphorylation of heat shock protein 27 (HSP27), a substrate for MAPKAPK-2, also was detected post-irradiation. Oral administration of the p38 inhibitor, SB242235, prior to UVB irradiation, blocked activation of the p38 MAPK cascade, and abolished MAPKAPK-2 kinase activity and phosphorylation of HSP27. Moreover, SB242235 inhibited expression of the pro-inflammatory cytokines interleukin (IL)-6 and KC (murine IL-8) and COX-2. Our data demonstrate that UVB irradiation of murine skin activates epidermal p38 MAPK signaling and induces a local pro-inflammatory response. Blockade of the p38 MAPK pathway may offer an effective approach to reducing or preventing skin damage resulting from acute solar radiation.
引用
收藏
页码:1318 / 1325
页数:8
相关论文
共 62 条
  • [1] Pyrimidinylimidazole inhibitors of p38: Cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity
    Adams, JL
    Boehm, JC
    Gallagher, TF
    Kassis, S
    Webb, EF
    Hall, R
    Sorenson, M
    Garigipati, R
    Griswold, DE
    Lee, JC
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (21) : 2867 - 2870
  • [2] Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes
    Adams, JL
    Boehm, JC
    Kassis, S
    Gorycki, PD
    Webb, EF
    Hall, R
    Sorenson, M
    Lee, JC
    Ayrton, A
    Griswold, DE
    Gallagher, TF
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (22) : 3111 - 3116
  • [3] Deficiency of the stress kinase p38α results in embryonic lethality:: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells
    Allen, M
    Svensson, L
    Roach, M
    Hambor, J
    McNeish, J
    Gabel, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) : 859 - 869
  • [4] An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO
  • [5] 2
  • [6] CYTOKINE MODULATION OF KERATINOCYTE CYTOKINES
    ANSEL, J
    PERRY, P
    BROWN, J
    DAMM, D
    PHAN, T
    HART, C
    LUGER, T
    HEFENEIDER, S
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (06) : S101 - S107
  • [7] Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation
    Antille, C
    Tran, C
    Sorg, O
    Carraux, P
    Didierjean, L
    Saurat, JH
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (05) : 1163 - 1167
  • [8] Transforming growth factor-alpha induces interleukin-6 in the human keratinocyte cell line HaCaT mainly by transcriptional activation
    Aragane, Y
    Yamada, H
    Schwarz, A
    Poppelmann, BP
    Luger, TA
    Tezuka, T
    Schwarz, T
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (06) : 1192 - 1197
  • [9] Involvement of EGF receptor activation in the induction of cyclooxygenase-2 in HaCaT keratinocytes after UVB
    Ashida, M
    Bito, T
    Budiyanto, A
    Ichihashi, M
    Ueda, M
    [J]. EXPERIMENTAL DERMATOLOGY, 2003, 12 (04) : 445 - 452
  • [10] Asschert JGW, 1999, INT J CANCER, V82, P244, DOI 10.1002/(SICI)1097-0215(19990719)82:2<244::AID-IJC15>3.0.CO